{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:15:58Z","timestamp":1791166558840,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2002]]},"DOI":"10.1080\/00313020212469","type":"journal-article","created":{"date-parts":[[2003,9,24]],"date-time":"2003-09-24T17:45:27Z","timestamp":1064425527000},"page":"213-224","source":"Crossref","is-referenced-by-count":48,"title":["Human papillomavirus update with a particular focus on cervical disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Suzanne M.","family":"Garland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1080\/00313020212469_bib0005","series-title":"Monographs on the Evaluation of the Carcinogenic Risks to Humans","year":"1995"},{"key":"10.1080\/00313020212469_bib0010","series-title":"A multinational case-control study on the risk of cervical cancer linked to 25 HPV types: which are the high-risk types?","first-page":"21","author":"Munoz","year":"2000"},{"key":"10.1080\/00313020212469_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1080\/00313020212469_bib0020","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.1. IARC Cancer Base No. 5. Lyon: IARC Press, 2001. http:\/\/www-dep.iarc.fr\/globocan\/globocan.html"},{"key":"10.1080\/00313020212469_bib0025","first-page":"607","article-title":"Control of cancer of the cervix uteri: review article based on a report of a WHO meeting, November 1985, Geneva","volume":"64","year":"1986","journal-title":"Bull World Health Org"},{"key":"10.1080\/00313020212469_bib0030","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(87)92695-X","article-title":"Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes","volume":"i","author":"Laara","year":"1987","journal-title":"Lancet"},{"key":"10.1080\/00313020212469_bib0035","series-title":"Sexually Transmitted Diseases","first-page":"335","article-title":"Biology of genital human papillomaviruses","author":"Galloway","year":"1999"},{"key":"10.1080\/00313020212469_bib0040","first-page":"57","article-title":"Taxonomic classification of papillomaviruses","volume":"12","author":"de Villiers","year":"2001","journal-title":"Papillomavirus Rep"},{"key":"10.1080\/00313020212469_bib0045","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ijc.2910250509","article-title":"Partial characterisation of viral DNA from human genital warts","volume":"25","author":"Gissmann","year":"1980","journal-title":"Int J Cancer"},{"key":"10.1080\/00313020212469_bib0050","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/JVI.64.7.3310-3318.1990","article-title":"Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice","volume":"64","author":"Stoler","year":"1990","journal-title":"J Virol"},{"key":"10.1080\/00313020212469_bib0055","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.6.7.1131","article-title":"Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures","volume":"6","author":"Dollard","year":"1992","journal-title":"Genes Dev"},{"key":"10.1080\/00313020212469_bib0060","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1054\/bjoc.2001.1695","article-title":"Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix","volume":"84","author":"Giannoudis","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1080\/00313020212469_bib0065","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/JVI.69.5.3074-3083.1995","article-title":"Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy","volume":"69","author":"Chan","year":"1995","journal-title":"J Virol"},{"key":"10.1080\/00313020212469_bib0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5694\/j.1326-5377.1992.tb139710.x","article-title":"Cervical cancer \u2013 what role for human papillomavirus?","volume":"156","author":"Garland","year":"1992","journal-title":"Med J Aust"},{"key":"10.1080\/00313020212469_bib0075","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1054\/bjoc.2000.1509","article-title":"Progressive genetic aberrations detected by comparative genomic hybridization in clinical stage 1B squamous cell cancer","volume":"83","author":"Allen","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1080\/00313020212469_bib0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.2157286","article-title":"Association of human papillomavirus types 16 and 18 E6 proteins with p53","volume":"248","author":"Werness","year":"1990","journal-title":"Science"},{"key":"10.1080\/00313020212469_bib0085","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.2537532","article-title":"The human papillomavirus\u201316 E7 oncoprotein is able to bind to the retinoblastoma gene product","volume":"243","author":"Dyson","year":"1989","journal-title":"Science"},{"key":"10.1080\/00313020212469_bib0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/15513819709168346","article-title":"Juvenile laryngeal papillomatosis in a paediatric population: a clinicopathologic study","volume":"17","author":"Somers","year":"1997","journal-title":"Pediatr Pathol Lab Med"},{"key":"10.1080\/00313020212469_bib0095","first-page":"755","article-title":"Human papillomavirus infection and its relationship to recent and distant sexual partners","volume":"84","author":"Fairley","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1080\/00313020212469_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"key":"10.1080\/00313020212469_bib0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"New Engl J Med"},{"key":"10.1080\/00313020212469_bib0110","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","article-title":"Natural history of cervical human papillomavirus in young women: a longitudinal cohort study","volume":"357","author":"Woodman","year":"2001","journal-title":"Lancet"},{"key":"10.1080\/00313020212469_bib0115","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ajcp\/102.6.768","article-title":"Immunological events in regressing genital warts","volume":"102","author":"Coleman","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1080\/00313020212469_bib0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/315706","article-title":"Persistence of human papillomavirus 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigen","volume":"182","author":"Nakagawa","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1080\/00313020212469_bib0125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/infdis\/174.5.927","article-title":"The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women","volume":"174","author":"Carter","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1080\/00313020212469_bib0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9378(16)40621-6","article-title":"The diagnostic value of vaginal smears in carcinoma of uterus","volume":"42","author":"Papanicolaou","year":"1941","journal-title":"Am J Obstet Gynecol"},{"key":"10.1080\/00313020212469_bib0135","series-title":"The Epidemiology of Cervical Cancer and Human Papillomavirus","first-page":"59","article-title":"Reassessment of the morphological continuum of cervical intraepithelial lesions: does it reflect different stages in the progression to cervical carinoma?","author":"Kiviat","year":"1992"},{"key":"10.1080\/00313020212469_bib0140","first-page":"1892","article-title":"The revised Bethesda System for reporting cervical\/vaginal cytological diagnoses: report of the 1991 Bethesda Workshop","volume":"267","year":"1991","journal-title":"J Am Med Assoc"},{"key":"10.1080\/00313020212469_bib0145","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jama.281.17.1605","article-title":"Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results","volume":"281","author":"Manos","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1080\/00313020212469_bib0150","first-page":"1077","article-title":"Bethesda System","volume":"45","author":"Solomon","year":"2001","journal-title":"Acta Cytol"},{"key":"10.1080\/00313020212469_bib0155","series-title":"The natural history of cervical HPV infection and neoplasia in a large population-based prospective study: The Manchester Cohort","first-page":"21","author":"Peto","year":"2000"},{"key":"10.1080\/00313020212469_bib0160","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1128\/JCM.36.11.3248-3254.1998","article-title":"Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies","volume":"36","author":"Peyton","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1080\/00313020212469_bib0165","first-page":"209","article-title":"The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses","volume":"7","author":"Manos","year":"1989","journal-title":"Cancer Cells"},{"key":"10.1080\/00313020212469_bib0170","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1099\/0022-1317-76-4-1057","article-title":"The use of general primers GP5 and GP6 elongated at their 3\u2032 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR","volume":"76","author":"de Roda Husman","year":"1985","journal-title":"J Gen Virol"},{"key":"10.1080\/00313020212469_bib0175","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0002-9440(10)65688-X","article-title":"Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses","volume":"153","author":"Kleter","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1080\/00313020212469_bib0180","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","article-title":"Improved amplification of genital human papillomavirus","volume":"38","author":"Gravitt","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1080\/00313020212469_bib0185","series-title":"New method for the detection and genotyping of human papillomavirus: HPV DNA chip","author":"Sangwon","year":"2001"},{"key":"10.1080\/00313020212469_bib0190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jcp.33.6.517","article-title":"Progression and regression of cervical lesions. Review of smears from women followed without initial biopsy or treatment","volume":"33","author":"Spriggs","year":"1980","journal-title":"J Clin Pathol"},{"key":"10.1080\/00313020212469_bib0195","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00006250-198605000-00012","article-title":"Behaviour of mid-cervical dysplasia during long-term follow-up","volume":"67","author":"Nasiell","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1080\/00313020212469_bib0200","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/91.3.252","article-title":"Natural history of dysplasia of the uterine cervix","volume":"91","author":"Holowaty","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1080\/00313020212469_bib0205","series-title":"HPV international prevalence surveys in general populations","first-page":"21","author":"Herrero","year":"2000"},{"key":"10.1080\/00313020212469_bib0210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjc.6600194","article-title":"Prevalence and determinants of human papillomavirus genital infection in men","volume":"86","author":"Franceschi","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1080\/00313020212469_bib0215","series-title":"The risk of cervical cancer in relation to hormonal contraceptives in women that are HPV-DNA carriers. Pooled analysis of the IARC multicentric case\u2013control study","first-page":"21","author":"Moreno","year":"2000"},{"key":"10.1080\/00313020212469_bib0220","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1054\/bjoc.2001.1779","article-title":"HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica","volume":"84","author":"Hildesheim","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1080\/00313020212469_bib0225","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00002018-200124100-00003","article-title":"Oral contraceptives and cancer: an update","volume":"24","author":"La Vecchia","year":"2001","journal-title":"Drug Saf"},{"key":"10.1080\/00313020212469_bib0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00007435-200104000-00001","article-title":"Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines","volume":"28","author":"Smith","year":"2001","journal-title":"Sex Transm Dis"},{"key":"10.1080\/00313020212469_bib0235","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1086\/338569","article-title":"Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines","volume":"185","author":"Smith","year":"2002","journal-title":"Am J Infect Dis"},{"key":"10.1080\/00313020212469_bib0240","first-page":"659","article-title":"Human papillomavirus infections in women with HIV disease: prevalence, risk, and management","volume":"10","author":"Jay","year":"2000","journal-title":"AIDS Read"},{"key":"10.1080\/00313020212469_bib0245","unstructured":"Centres for Disease Control and Prevention. US HIV and AIDS cases reported through December 1999. http:\/\/www.cdc.gov"},{"key":"10.1080\/00313020212469_bib0250","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0168-1702(93)90077-Z","article-title":"The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription","volume":"27","author":"Vernon","year":"1993","journal-title":"Virus Res"},{"key":"10.1080\/00313020212469_bib0255","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/318071","article-title":"Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women","volume":"183","author":"Palefsky","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1080\/00313020212469_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910600102","article-title":"Strategies for global control of cervical cancer","volume":"60","author":"Ponten","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1080\/00313020212469_bib0265","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ijc.2910610305","article-title":"The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months","volume":"61","author":"Remmink","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1080\/00313020212469_bib0270","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.283.1.87","article-title":"HPV DNA testing in cervical cancer screening. Results from women in a high-risk province of Costa Rica","volume":"283","author":"Schiffman","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1080\/00313020212469_bib0275","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1054\/bjoc.2001.1845","article-title":"Human papillomavirus testing in primary screening of high-grade cervical lesions: a study of 7932 women","volume":"89","author":"Clavel","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1080\/00313020212469_bib0280","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial","volume":"93","author":"Solomon","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1080\/00313020212469_bib0285","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.283.1.81","article-title":"HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer","volume":"283","author":"Wright","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1080\/00313020212469_bib0290","first-page":"6132","article-title":"Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes","volume":"59","author":"Klaes","year":"1999","journal-title":"Cancer Res"},{"key":"10.1080\/00313020212469_bib0295","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","article-title":"Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri","volume":"92","author":"Klaes","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1080\/00313020212469_bib0300","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3310\/hta3140","article-title":"A systematic review of the role of human papillomavirus testing within a cervical screening programme","volume":"3","author":"Cuzick","year":"1999","journal-title":"Health Technol Assess"},{"key":"10.1080\/00313020212469_bib0305","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z","article-title":"PCR based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears","volume":"68","author":"Rozendaal","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1080\/00313020212469_bib0310","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1067\/mob.2000.105871","article-title":"Two-stage cervical cancer screening: an alternative for resource-poor settings","volume":"183","author":"Denny","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1080\/00313020212469_bib0315","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(98)07033-0","article-title":"Visual inspection with acetic acid for cervical-cancer screen: test qualities in a primary-care setting","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1080\/00313020212469_bib0320","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0140-6736(98)00417-6","article-title":"Detection of cervical intraepithelial neoplasia in developing countries. (Commentary.)","volume":"353","author":"Kitchener","year":"1999","journal-title":"Lancet"},{"key":"10.1080\/00313020212469_bib0325","series-title":"Screening for the prevention of cervical cancer: Guidelines for the management of women with screen detected abnormalities","year":"1994"},{"key":"10.1080\/00313020212469_bib0330","unstructured":"Garland SM. Genital warts and HPV infection: diagnosis and management. Mod Med Aust 1997; 119\u201325."},{"key":"10.1080\/00313020212469_bib0335","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1258\/0956462011924218","article-title":"Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts \u2013 results of an open-label, multicentre Phase IIIB trial","volume":"12","author":"Garland","year":"2001","journal-title":"Int J STD AIDS"},{"key":"10.1080\/00313020212469_bib0340","first-page":"23","article-title":"Mechanism of action of imiquimod","volume":"10","author":"Stanley","year":"1999","journal-title":"Papillomavirus Rep"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251634466X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251634466X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T13:24:44Z","timestamp":1623417884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003130251634466X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002]]}},"alternative-id":["S003130251634466X"],"URL":"https:\/\/doi.org\/10.1080\/00313020212469","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}